Proadrenomedullin NH2-terminal 20 peptide has direct vasodilator activity in the cat

American Journal of Physiology

Volumn 272, Issue 4 PART 2, 1997, Pages

  Champion, Hunter C ^a   Murphy, William A ^a   Coy, David H ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745358196     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bellan, J. A., D. B. McNamara, and P. J. Kadowitz. Differential effects of nitric oxide synthesis inhibitor on vascular resistance and responses to acetylcholine in the cat. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H45-H56, 1993.
2. ω-nitro-L-arginine selectively inhibits vasodilator responses to acetylcholine and bradykinin in cats. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H1025-H1029, 1991.
3. Champion, H. C., J. A. Santiago, W. A. Murphy, D. H. Coy, and P. J. Kadowitz. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedulhn in the cat. Am. J. Physiol. 212 (Regulatory Jntegrative Comp. Physiol. 41): 234-242, 1997.
4. DiSanto, M. E., and R. J. Heaslip. Rolipram inhibition of phosphodiesterase-4 activation. Ear. J. Pharmacol. 290: 169-172, 1995.
5. Entzeroth, M., H. N. Doods, H. A. Wieland, and W. Wienen. Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sei. 56: PL-19-PL-25, 1995.
6. Peng, C. J., B. Rang, A. D. Kaye, P. J. Kadowitz, and B. D. Nossaman. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sei. 55: PL-433-PL-438, 1994.
7. Harris, A. L., B. M. Lemp, R. G. Bentley, M. H. Perrone, L. T. Hamel, and P. J. Silver. Phosphodiesterase isozyme inhibition and the potentiation by Zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agems in vascular smooth muscle. J. Pharmacol. Exp. Ther. 249: 394-400, 1989.
8. Ichiki, Y., K. Kitamura, K. Kangawa, M. Kawamoto, H. Matsuo, and T. Eto. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEES Lett. 338: 6-10, 1994.
9. Ishimitsu, T., T. Nishikimi, Y. Saito, K. Kitamura, T. Eto, K. Kangawa, H. Matsuo, T. Omae, and H. Matsuoka. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest. 94:2158-2161, 1994.
10. Ishizaka, Y., M. Tanaka, K. Kitamura, K. Kangawa, N. Minamino, H. Matsuo, and T. Eto. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 200: 642-646, 1994.
11. Jougasaki, M., R. J. Rodeheffer, M. M. Red Held, K. Yamamoto, C. Wei, L. J. McKinley, and J. C. Burnett. Cardiac secretion of adrenomedullin in human heart failure. J. Clin. Invest. 97: 2370-2376, 1996.
12. Jougasaki, M., C. Wei, L. J. McKinley, and J. C. Burnett. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92: 286-289, 1995.
13. Jougasaki, M., C. M. Wei, L. L. Aarhus, D. M. Heublein, S. M. Sandberg, and J. C. Burnett. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F657-F663, 1995.
14. Kitamura, K., K. Kangawa, Y. Ishiyama, H. Wahimine, Y. Ichiki, M. Kawamoto, N. Minamino, H. Matsuo, and T. Eto. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide. FEES Lett. 351: 35-37, 1994.
15. Kitamura, K., K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura, H. Matsuo, and T. Eto. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192: 553-560, 1993.
16. Kitamura, K., K. Kangawa, M. Kojima, Y. Ichicki, H. Matsuo, and T. Eto. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEES Lett. 338: 306-310, 1994.
17. Kitamura, K., J. Sakata, K. Kangawa, M. Kojima, H. Matsuo, and T. Eto. Cloning and characterization of c.DNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194: 720-725, 1993.
18. Kohno, M., T. Hanehira, H. Kano, T. Horio, K. Yokokawa, M. Ikeda, M. Minami, K. Yasunari, and J. Yoshikawa. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 27: 102-107, 1996.
19. Kuwasako, K., K. Kitamura, Y. Ichiki, J. Kato, K. Kangawa, H. Matsuo, and T. Eto. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla. Biochem. Biophys. Res. Commun. 211: 694-699, 1995.
20. Majid, D. S. A., P. J. Kadowitz, D. H. Coy, and L. G. Navar. Renal responses to intra-arterial administration of adrenomedullin in dogs. Am. J. Phvsiol. 270 (Renal Fluid Electrolyte Physiol. 39): F200-F205, 1996.
21. ATP channels and EDRF in reactive hyperemia in the hindquarters vascular bed of cats. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1704-H1712, 1995.
22. Nossaman, B. D., C. J. Feng, A. D. Kaye, B. J. DeWitt, D. H. Coy, W. A. Murphy, and P. J. Kadowitz. Pulmonary vasodilator responses to adrenomedullin are reduced by nitric oxide synthetase inhibitors in the rat but not in the cat. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L782-L789,1996.
23. Sakata, J., T. Shimokubo, K. Kitamura, S. Nakamura, K. Kangawa, H. Matsuo, and T. Eto. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195: 921-927, 1993.
24. Santiago, J. A., E. A. Garrison, V. L. Ventura, D. H. Coy, K. Bitar, W. A. Murphy, D. B. McNamara, and P. J. Kadowitz. Synthetic human adrenomedullin and adrenomedullin 15-52 have potent short-lived vasodilator activity in the hindlimb vascular bed of the cat. Life Sei. 55: PL-85-PL-90,1994.
25. Shimosawa, T., Y. Ito, K. Ando, K. Kitamura, K. Kangawa, and T. Fujita. Proadrenomedullin NH2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J. Clin. Invest. 96: 1672-1676, 1995.
26. Shimosawa, T., and T. Fujita. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension 28: 325-329, 1996.
27. Snedecor, G. W., and W. G. Cochran. Statistical Methods (6th ed.). Ames: Iowa State Univ. Press, 1967, p. 258-338.
28. Vari, R. C., S. D. Adkins, and W. K. Samson. Renal effects of adrenomedullin in the rat. Proc. Soc. Exp. Biol. Med. 211: 178-183, 1995.
29. Washimine, H., K. Kitamura, Y. Ichiki, Y. Yamamoto, K. Kangawa, H. Matsuo, and T. Eto. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem. Biophys. Res. Commun. 202: 1081-1087,1994.